Mascarell; Laurent

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mascarell; Laurent.The latest application filed is for "il-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy".

Company Profile

4.7.7

Mascarell; Laurent - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy Grant 11,028,441 - Mascarell , et al. June 8, 2	2021-06-08
Markers of immune response Grant 11,015,221 - Mascarell , et al. May 25, 2	2021-05-25
Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy Grant 10,190,166 - Moingeon , et al. Ja	2019-01-29
Il-10 As A Predictive Biomarker Of Responsiveness To House Dust Mite Allergen Immunotherapy App 20190024177 - MASCARELL; Laurent ; et al.	2019-01-24
Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa Grant 9,822,185 - Batard , et al. November 21, 2	2017-11-21
Markers Of Immune Response App 20170233816 - MASCARELL; Laurent ; et al.	2017-08-17
Composition Of Allergen Extracts Having Reduced Toxicity And Method Of Production Thereof App 20170157240 - NONY; Emmanuel ; et al.	2017-06-08
Use Of Igg1 Immunoglobulins And/or Ligands Of The Cd32 Receptor For Treating Inflammatory Diseases And Incidents Via The Mucosa App 20160032018 - Batard; Thierry ; et al.	2016-02-04
Use of IgG.sub.1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route Grant 9,187,568 - Batard , et al. November 17, 2	2015-11-17
Methods For Identifying Dendritic Cell Subsets, For Determining If A Patient Is Developing A Regulatory Or An Effector Immune Response, And For Determining Response To Immunotherapy App 20140377761 - Moingeon; Philippe ; et al.	2014-12-25
Use Of Igg1 Immunoglobulins And/or Ligands Of The Cd32 Receptor For Treating Inflammatory Diseases And Manifestations Via The Mucosal Route App 20120171198 - Batard; Thierry ; et al.	2012-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.